Advertisement
Canada markets open in 39 minutes

  • S&P/TSX

    21,873.72
    -138.00 (-0.63%)
     

  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     

  • DOW

    38,460.92
    -42.77 (-0.11%)
     

  • CAD/USD

    0.7293
    -0.0004 (-0.06%)
     

  • CRUDE OIL

    83.01
    +0.20 (+0.24%)
     

  • Bitcoin CAD

    87,182.50
    -3,852.92 (-4.23%)
     

  • CMC Crypto 200

    1,358.65
    -23.92 (-1.73%)
     

  • GOLD FUTURES

    2,340.40
    +2.00 (+0.09%)
     

  • RUSSELL 2000

    1,995.43
    -7.22 (-0.36%)
     

  • 10-Yr Bond

    4.6810
    +0.0290 (+0.62%)
     

  • NASDAQ futures

    17,409.00
    -255.50 (-1.45%)
     

  • VOLATILITY

    16.48
    +0.51 (+3.20%)
     

  • FTSE

    8,089.65
    +49.27 (+0.61%)
     

  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     

  • CAD/EUR

    0.6820
    +0.0001 (+0.01%)
     
MARKETS LIVE BLOG:

STOCK FUTURES SLIDE AFTER META'S REALITY CHECK, WITH GDP ON DECK

Owner of Facebook and Instagram plans to spend up to US$10B on AI infrastructure investments

Stocks in play: MedReleaf Corp.

Baystreet.ca
Updated

Announced financial and operating results for the year end fiscal 2018 ending March 31, 2018. Record sales of $43.6 million, an increase of 8%, compared to the prior fiscal year. Adjusted EBITDA loss of $2.3 million, compared to $13.9 million for the prior fiscal year due to increased overhead costs and investments in recreational brands, international business initiatives, and increased research and development efforts. MedReleaf Corp. shares T.LEAF are trading up $0.64 at $27.30.